Terrestrial, a Woburn-based biotechnology company developing a Microneedle Array Patch (MAP) platform for delivering therapies and vaccines, recently received $850,000 through the Massachusetts Manufacturing Innovation Initiative (M2I2). The program, administered by the Healey-Driscoll Administration and the Center for Advanced Manufacturing (CAM), a division of the Massachusetts Technology Collaborative (MassTech), provides capital grant funding to help Massachusetts manufacturers expand production, create jobs, and strengthen key innovation sectors. Terrestrial’s award was part of a broader $1.85 million announcement supporting three Massachusetts manufacturing companies which are expected to create 62 jobs across the state.
With this award, Terrestrial will automate and scale its manufacturing line in Woburn to produce thousands of MAPs per month. The company will also partner with Bunker Hill Community College and North Shore Community College to establish internship and apprenticeship opportunities, publish research, and collaborate with MassMEP to share best practices with fellow manufacturing companies across the Commonwealth.
In addition to the M2I2 award, Terrestrial recently received a BioBoost award of more than $1.4 million from the Massachusetts Life Sciences Center (MLSC) to support the buildout of the world’s first commercial-scale therapeutic microarray patch manufacturing headquarters in Boston, which is expected to open later this year. Since its inception, Terrestrial has been awarded nearly $2.9 million in MLSC funding and has hosted 15 interns through the MLSC’s Internship Challenge.
